Literature DB >> 16950241

Overlapping expression of FoxA and Zic confers responsiveness to FGF signaling to specify notochord in ascidian embryos.

Gaku Kumano1, Satoshi Yamaguchi, Hiroki Nishida.   

Abstract

Differences in cell responsiveness to an inductive signal contribute to the emergence of a variety of tissue types during animal development. In ascidian embryos, the Fibroblast Growth Factor (FGF) signal secreted from endoderm cells induces several different tissue types, such as notochord, mesenchyme and brain, at different positions in the embryo at the 32-cell stage. We show here in Halocynthia roretzi that FoxA and Zic are required for notochord formation in cells that receive the FGF signal. We also show that these transcription factors, only when both are supplied, are able to induce ectopic expression of the brachyury gene, a notochord-specific marker, in cells of all the three germ layers in an FGF-dependent manner. These results suggest that FoxA and Zic confer notochord-specific responsiveness to FGF signaling. Further analyses including knockdown and over-expression experiments showed that combinatorial inputs from maternally supplied and zigotically activated factors lead to overlapping expression of FoxA and Zic in the presumptive notochord cells, which eventually activate the expression of the brachyury gene in cooperation with FGF signaling. Our data illustrate how a complex gene network specifies the notochord at its specific position within the embryo.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16950241     DOI: 10.1016/j.ydbio.2006.07.033

Source DB:  PubMed          Journal:  Dev Biol        ISSN: 0012-1606            Impact factor:   3.582


  11 in total

1.  Initial deployment of the cardiogenic gene regulatory network in the basal chordate, Ciona intestinalis.

Authors:  Arielle Woznica; Maximilian Haeussler; Ella Starobinska; Jessica Jemmett; Younan Li; David Mount; Brad Davidson
Journal:  Dev Biol       Date:  2012-05-14       Impact factor: 3.582

2.  Brain induction in ascidian embryos is dependent on juxtaposition of FGF9/16/20-producing and -receiving cells.

Authors:  Yuriko Miyazaki; Hiroki Nishida; Gaku Kumano
Journal:  Dev Genes Evol       Date:  2007-01-11       Impact factor: 0.900

Review 3.  The conserved role and divergent regulation of foxa, a pan-eumetazoan developmental regulatory gene.

Authors:  Smadar Ben-Tabou de-Leon
Journal:  Dev Biol       Date:  2010-12-03       Impact factor: 3.582

4.  Brachyury null mutant-induced defects in juvenile ascidian endodermal organs.

Authors:  Shota Chiba; Di Jiang; Noriyuki Satoh; William C Smith
Journal:  Development       Date:  2008-11-19       Impact factor: 6.868

Review 5.  Ascidians and the plasticity of the chordate developmental program.

Authors:  Patrick Lemaire; William C Smith; Hiroki Nishida
Journal:  Curr Biol       Date:  2008-07-22       Impact factor: 10.834

6.  Brachyury controls Ciona notochord fate as part of a feed-forward network.

Authors:  Wendy M Reeves; Kotaro Shimai; Konner M Winkley; Michael T Veeman
Journal:  Development       Date:  2021-02-05       Impact factor: 6.868

7.  FGF9/16/20 and Wnt-5alpha signals are involved in specification of secondary muscle fate in embryos of the ascidian, Halocynthia roretzi.

Authors:  Miki Tokuoka; Gaku Kumano; Hiroki Nishida
Journal:  Dev Genes Evol       Date:  2007-05-30       Impact factor: 2.116

8.  Regulation of the number of cell division rounds by tissue-specific transcription factors and Cdk inhibitor during ascidian embryogenesis.

Authors:  Mami Kuwajima; Gaku Kumano; Hiroki Nishida
Journal:  PLoS One       Date:  2014-03-07       Impact factor: 3.240

9.  Expression of Hr-Erf Gene during Ascidian Embryogenesis.

Authors:  Jung Eun Kim; Won Young Lee; Gil Jung Kim
Journal:  Dev Reprod       Date:  2013-12

10.  Co-expression of Foxa.a, Foxd and Fgf9/16/20 defines a transient mesendoderm regulatory state in ascidian embryos.

Authors:  Clare Hudson; Cathy Sirour; Hitoyoshi Yasuo
Journal:  Elife       Date:  2016-06-28       Impact factor: 8.140

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.